• 제목/요약/키워드: Intravenous Sedation

검색결과 128건 처리시간 0.024초

비글견에서 medetomidine-midazolam-ketamine 마취에 대한 atipamezole과 yohimbine의 길항효과 (Antagonistic Effects of Atipamezole and Yohimbine on Medetomidine-Midazolam-Ketamine Anesthesia in Beagle Dogs)

  • 황학균;이재연;정성목;김명철
    • 한국임상수의학회지
    • /
    • 제28권2호
    • /
    • pp.211-218
    • /
    • 2011
  • 개에서 많은 주사용 마취제가 있고 그 부작용을 줄이기 위해 다양한 약물들을 혼합하여 사용한다. 개에서 medetomidine-midazolam-ketamine (MMK) 합제에 대한 마취효과를 알아보고, 이 합제에 대한 atipamezole과 yohimbine의 길항효과를 비교하였다. 18마리 수컷 비글견을 사용하였고, 모든 개에서 medetomidine (0.04 mg/kg), midazolam (0.2 mg/kg) 및 ketamine (5 mg/kg)을 근육주사하고, 20분 후 atipamezole (0.24 mg/kg, MMKA), yohimbine (0.2 mg/kg, MMKY) 또는 생리식염수(0.1 ml/kg, MMK)를 정맥주사하였다. 유도 및 회복시간, 진정 및 진통점수, 심박수, 혈압, 직장온도, 호흡수, 동맥혈액가스를 측정하였다. 평균마취, 흉와, 기립 및 보행시간은 MMKA와 MMKY군에서 MMK군보다 유의성있게 짧았다. 그러나 MMKA군과 MMKY군 간의 유의적인 차이는 없었다. 모든 군에서 MMK 투여는 개에서 만족스런 진정 및 진통을 일으켰다. 그러나 atipamezole이나 yohimbine 투여 후 자세점수 및 유해자극반응은 MMK군에 비해 MMKA나 MMKY군에서 유의성있게 감소하였다. 본 실험 결과 MMK는 양호한 진정 및 마취효과를 나타냈고, atipamezole과 yohimbine은 개에서 MMK 마취를 길항하는 데 안전하고 효과적으로 사용될 수 있을 것으로 사료된다.

장애 환자의 전신 마취를 위한 세보플루란 흡입 유도 시 발생한 호흡 저하의 혈액 가스 분석 (Blood Gas Analysis of Respiratory Depression during Sevoflurane Inhalation Induction for General Anesthesia in the Disabled Patients)

  • 윤태완;김승오
    • 대한소아치과학회지
    • /
    • 제45권4호
    • /
    • pp.508-513
    • /
    • 2018
  • 세보플루란에 의한 일회 환기량은 낮은 용량에서는 호흡수의 증가로 안정적이다. 그러나 진정 깊이가 증가하면 폐포 환기는 세보플루란에 의해 감소되어 결과적으로는 $PaCO_2$가 증가한다. 호흡 억제의 발생은 깊이 진정된 장애 환자에서 심한 저산소증과 고탄산혈증의 위험을 증가시킨다. 세보플루란 흡입 마취는 여러 위험성이 내제되어 있으며 체내 산 염기 상태에 따라 혈역학적 변화가 발생하기에 예기치 못한 문제 상황이 발생할 수 있다. 세보플루란으로 장애인의 마취 유도 시 발생하는 호흡 억제로 인한 체내 산 염기 상태가 안정한지 알아보고자 이 연구를 진행하였다. 마취 유도는 4 vol% 세보플루란, 4 L/min 아산화질소, 4 L/min 산소를 자발 호흡 하에서 환자 안면부에 마스크를 거치하여 유도하였다. 그 뒤 환자의 의식소실 및 근육 긴장 완화 후 즉시 전문가에 의해 IV line을 거치한 뒤 정맥 채혈을 하여 정맥 내 혈액가스 분석을 하였다. 깊은 진정 상태에서 전체 환자의 평균 pH는 $7.36{\pm}0.06$으로 측정되었다. $PvCO_2$는 전체 환자에서는 평균 $48.8{\pm}8.50mmHg$로 측정되었다. $HCO_3{^-}$는 전체 환자에서 평균 $27.2{\pm}3.0mmol/L$로 측정되었다. 결론적으로 장애인을 대상으로 한 치과 진료시 세보플루란을 이용한 흡입 진정에 대한 체내 산 염기 반응은 비교적 안정적이었다.

Full mouth rehabilitation of a patient with Sturge-Weber syndrome using a mixture of general and sedative anesthesia

  • Doh, Re-Mee;Yu, Tae-min;Park, Wonse;Kim, Seungoh
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • 제15권3호
    • /
    • pp.173-179
    • /
    • 2015
  • Issues related to the control of seizures and bleeding, as well as behavioral management due to mental retardation, render dental treatment less accessible or impossible for patients with Sturge-Weber syndrome (SWS). A 41-year-old man with SWS visited a dental clinic for rehabilitation of missing dentition. A bilateral port-wine facial nevus and intraoral hemangiomatous swollen lesion of the left maxillary and mandibular gingivae, mucosa, and lips were noted. The patient exhibited extreme anxiety immediately after injection of a local anesthetic and required various dental treatments to be performed over multiple visits. Therefore, full-mouth rehabilitation over two visits with general anesthesia and two visits with target-controlled intravenous infusion of a sedative anesthesia were planned. Despite concerns regarding seizure control, bleeding control, and airway management, no specific complications occurred during the treatments, and the patient was satisfied with the results.

Cleft Palate and Congenital Alveolar Synechiae Syndrome: A Case Report and Literature Review

  • Choi, Kang-Young;Chung, Ki-Ho;Yang, Jung-Dug;Chung, Ho-Yun;Cho, Byung-Chae
    • 대한두개안면성형외과학회지
    • /
    • 제9권1호
    • /
    • pp.41-44
    • /
    • 2008
  • Cleft palate and congenital alveolar synechia is a rare syndrome. Only eight cases have been previously reported. It consists of a spectrum of facial anomalies always including cleft palate and congenital alveolar synechiae without other abnormalities. This report described an unusual case of congenital alveolar synechial band spanning posterior alveolar of the two jaws with cleft palate. Previously reported cases showed bilaterally or anteriorly located fibrous band. In our department, a new born revealed unilateral posterior synechia. Under brief intravenous sedation, synechium was divided using bipolar diathermy in the nursery at 3 days of age because of poor feeding. This division allowed full jaw opening after brief passive exercise. The patient is growing and maturing as expected with no complications. This patient is supposed to be the first reported case of isolated unilateral alveolar synechium combined with cleft palate in the worldwide.

수면 무호흡증이 있는 양극성 장애 환자에서 급속 정온요법으로 인해 발생한 급성 호흡 장애 (Acute Respiratory Distress due to Rapid Tranquilization in a Bipolar Patient with Sleep Apnea)

  • 함병주;서용진;김린
    • 수면정신생리
    • /
    • 제8권2호
    • /
    • pp.144-147
    • /
    • 2001
  • Chemical restraint or "rapid tranquilization" is another option in treating patients who are a danger to themselves or others and struggle violently once physically restrained. The most commonly used drugs are benzodiazepines and antipsychotics. The use of benzodiazepines, either alone or in combination with high potency neuroleptics, has increased in recent years. Benzodiazepines are extremely safe but may cause respiratory depression and hypotension. Respiratory depression is more likely with intravenous administration, therefore these medications should be given slowly and titrated to the desired effect. Special care should be taken when sedating patients who are under the influence of alcohol or narcotics and are sleep apneic patients. This report deals with a case of respiratory distress in a patient with sleep apnea syndrome after the rapid tranqulization. All patients receiving chemical restraint must be carefully monitored. For critically ill patients who require sedation or chemical restraint, the constant attendance of a physician may be warranted.

  • PDF

개구 장애가 심한 소아환자에서 전신마취 하 치과치료를 위한 기도관리 (Dental Treatment of Pediatric Patients with Mouth Opening Limitation under General Anesthesia)

  • 한효조;서광석;김현정;신터전;권영선
    • 대한치과마취과학회지
    • /
    • 제11권2호
    • /
    • pp.172-176
    • /
    • 2011
  • For dental treatment of children with severe dental phobia, sedation or general anesthesia is usually selected for enhancement of cooperation. But in the case of mouth opening limitation due to temporomandibular disorders, general anesthesia administration is a challenge for anesthesiologist. Because airway management failure was concerned, awake fibroscopic intubation is selected first. But, skillful fibroscopic intubation is not easy in case of uncooprative children patients. In this report, we present two cases of pediatric patients with mouth opening limitation. In the first case, the patient was 52 months old and the maximum opening distance was 1.2 cm, and in the second case the patient was 38 months old and the maximum opening distance was 1.5 cm. Both patients showed severe dental phobia. After sevoflurane inhalation without any intravenous drug, we successfully performed intubation using a fibroscope.

Comparative randomized study of propofol target-controlled infusion versus sevoflurane anesthesia for third molar extraction

  • Chung, Patrick K;Dhanrajani, Parmanand
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • 제18권3호
    • /
    • pp.169-175
    • /
    • 2018
  • Background: The objective of this study was to compare hemodynamic and recovery characteristics of total intravenous anesthesia using propofol target-controlled infusion (TCI) versus sevoflurane for extraction of four third molar teeth. Methods: One hundred patients undergoing extraction of four third molar teeth under general anesthesia were randomized to one of two groups. Group 1 received propofol TCI-oxygen for induction and propofol TCI-oxygen-air for maintenance. Group II received a propofol bolus of 2 mg/kg for induction and sevoflurane-oxygen-air for maintenance. Heart rate, mean arterial pressure (MAP), operating time, time to emergence, nausea and vomiting, and sedation and pain scores were measured in each group. Results: Demographic data, including age, gender, weight, and height, were not significantly different between the two groups. The MAP was significantly higher after intubation (P = 0.007) and injection of anesthesia (P = 0.004) in the propofol group than in the sevoflurane group, with significant reflex bradycardia (P = 0.028). The mean time to emergence from anesthesia using propofol was 25 s shorter than that of sevoflurane (P = 0.02). Postoperatively, the propofol group was less sedated than the sevoflurane group at 30 min (0.02 versus 0.12), but this difference was not significant (P = 0.065). Conclusion: Both propofol TCI and sevoflurane are good alternatives for induction and maintenance of anesthesia for short day-case surgery. However, propofol TCI does not blunt the hemodynamic response to sudden, severe stimuli as strongly as sevoflurane, and this limitation may be a cause for concern in patients with cardiac comorbidities.

Treatment of severe pain in a patient with complex regional pain syndrome undergoing dental treatment under general anesthesia: A case report

  • Rhee, Seung-Hyun;Park, Sang-Hun;Ha, Sung-Ho;Ryoo, Seung-Hwa;Karm, Myong-Hwan;Kim, Hyun Jeong;Seo, Kwang-Suk
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • 제19권5호
    • /
    • pp.295-300
    • /
    • 2019
  • Complex regional pain syndrome (CRPS) is rare, characterized by pain from diverse causes, and presents as extreme pain even with minor irritation. General anesthesia may be required for dental treatment because the pain may not be controlled with local anesthesia. However, treatment under general anesthesia is also challenging. A 38-year-old woman with CRPS arrived for outpatient dental treatment under general anesthesia. At the fourth general anesthesia induction, she experienced severe pain resulting from her right toe touching the dental chair. Anesthesia was induced to calm her and continue the treatment. After 55 minutes of general anesthesia, the patient still complained of extreme toe pain. Subsequently, two administrations for intravenous sedation were performed, and discharge was possible in the recovery room approximately 5 h after the pain onset. The pain was not located at the dental treatment site. Although the major factor causing pain relief was unknown, ketamine may have played a role.

A new flap combination for reconstruction of lower nasal dorsum and supra-tip skin defects

  • Guesnier, Melanie;Claveleau, Xavier;Longeac, Marielle;Barthelemy, Isabelle;Dang, Nathalie Pham;Depeyre, Arnaud
    • Archives of Plastic Surgery
    • /
    • 제46권5호
    • /
    • pp.480-483
    • /
    • 2019
  • Repairing surgical defects of the nose is still challenging due to its tridimensional shape and its aesthetic concern. Difficulty in reconstructing nasal subunits lies in their contour, skin texture and limited availability of adjacent skin. For lower nasal dorsum and supra-tip regions, we design a new combined local flap as existing local flaps may give disappointing results. This combination flap was performed on two patients for reconstruction of the lower nasal dorsum area after basal cell carcinoma excision. Size of the excision ranged from 20 to 25 mm diameter and safe margins were obtained. The defects were reconstructed with a local flap that combined a rotation nasal flank flap and a V-Y advancement nasolabial flap. Excision and reconstruction were performed in a one-stage surgery under intravenous sedation and local anesthesia. There were no postoperative complications and no flap loss occurred. Aesthetic and functional results after 6 months postoperatively were satisfying without modification of nasal shape. This flap is reliable and offers interesting functional and aesthetic outcomes. It can be considered as a new reconstruction alternative for supra-tip and lower nasal dorsum skin defects performed in a one-stage procedure under local anesthesia.

개에서 Medetomidine과 Midazolam 병용 투여 시 Glycopyrrolate가 심맥관계에 미치는 영향 (Effect of Glycopyrrolate on Cardiovascular System in Dogs Sedated with Medetomidine-Midazolam Combination)

  • 한대경;신범준;이재연;지현철;박지영;김명철;정성목
    • 한국임상수의학회지
    • /
    • 제26권4호
    • /
    • pp.317-323
    • /
    • 2009
  • 이 연구는 혈관 내로 medetomidine (20 ${\mu}g$/kg)을 투여하고, 근육 내로 midazolam (0.3 mg/kg)을 투여한 개에서 혈관 내로 glycopyrroate를 투여하였을 때 심혈관계와 호흡기계에 미치는 영향을 평가하기 위해 실시하였다. 임상적으로 건강한 16마리의 중성화 하지 않은 비글견 (BW: 평균 8.35 kg)이 사용되었다. 혈관 내로 medetomidine과 근육내로 midazolam을 투여하기 전에 glycopyrrolate를 5 ${\mu}g$/kg (Gly-5), 10 ${\mu}g$/kg (Gly-10), 또는 20 ${\mu}g$/kg (Gly-20)의 용량으로 혈관 내로 투여하고, 대조군은 생리식염수를 혈관 내로 투여하였다. 심박수, 혈압(수축기 동맥압, 이완기 동맥압, 평균 동맥압), 우심방 동맥압, 폐동맥압, 폐동맥 쐐기압, 호흡수, 일회호흡량, 호기말 이산화탄소 분압을 환축감시기를 통해 직접 측정하였다. 심박출량을 측정하고, 계산공식으로 심박출계수, 일회심박출지수, 전신혈관 저항, 폐혈관 저항을 산출했다. 동맥혈을 채취하여 동맥혈 가스를 분석기로 분석하였다. Medetomidine/midazolam병용 투여의 부작용으로 심혈관계에서 서맥이 나타나고, 심박출량 감소와 전신혈관저항, 우심방압, 폐동맥 쐐기압은 증가 현상을 보였다. 서맥은 glycopyrrolate를 투여한 군에서는 나타나지 않았다. 그러나 Gly-10, Gly-20군에서는 빈맥이 관찰되었다. 전반적으로 glycopyrrolate를 투여한 군에서는 혈압은 상승하였으나, Gly-5 군의 경우 대조군과 유의적인 차이는 없었다. 심박출량 지수는 Gly-20군을 제외한 모든 군에서 medetomidine/ midazolam병용 투여 10분과 20분에 큰 차이는 보이지 않았다. 이상의 결과로 medetomidine/midazolam병용 투여는 빠르고 만족할 만한 진정을 보여주나, 현저한 심혈관 부작용이 관찰되고 혈관 내로 glycopyrrolate를 투여에 의해서도 큰 역전을 보이지 않는다. 이러한 결과로 medetomidine/midazolam병용 투여는 심폐기능 변화에 적응할 수 있는 건강한 개에서만 고려될 수 있는 방법이라고 생각된다.